The Belt and Road: Cooperation, Harmony and Win-Win
products

Products

2-Amino-3-(4-hydroxyphenyl)propanoic acid CAS:556-03-6

2-Amino-3-(4-hydroxyphenyl)propanoic acid, also known as L-DOPA or levodopa, is an amino acid precursor to dopamine, a neurotransmitter involved in various physiological functions, including motor control, mood regulation, and reward systems. L-DOPA is primarily used as a medication for the treatment of Parkinson’s disease, a neurodegenerative disorder characterized by a deficiency of dopamine in the brain. It is typically administered in combination with a peripheral decarboxylase inhibitor to prevent its conversion to dopamine outside the brain. L-DOPA can help alleviate the motor symptoms of Parkinson’s disease, such as tremors, rigidity, and bradykinesia.


Product Detail

Product Tags

Application and Effect

Effect on Parkinson's Disease: L-DOPA is the most effective medication for the treatment of Parkinson's disease. Parkinson's disease is caused by a deficiency of dopamine in specific areas of the brain. L-DOPA is a precursor to dopamine and can cross the blood-brain barrier to increase dopamine levels, thereby alleviating the motor symptoms of the disease.

Application in Parkinson's Disease Treatment: L-DOPA is commonly used in combination with a peripheral decarboxylase inhibitor (such as carbidopa) to enhance its effectiveness. The decarboxylase inhibitor prevents the conversion of L-DOPA to dopamine in the peripheral tissues, allowing more L-DOPA to reach the brain.

Management of Motor Symptoms: L-DOPA helps reduce the motor symptoms associated with Parkinson's disease, including tremors, rigidity, bradykinesia (slowness of movement), and postural instability. It improves motor function and allows patients to regain some control over their movements.

Side Effects: While L-DOPA is generally effective in managing Parkinson's symptoms, it can also lead to several side effects. These may include dyskinesias (involuntary movements), gastrointestinal issues (such as nausea, vomiting, and constipation), low blood pressure, hallucinations, and mood changes. The side effects can vary in severity and require careful monitoring and adjustment of the medication dosage.

Alternative Applications: Apart from Parkinson's disease treatment, L-DOPA has been explored for other applications. It has shown potential in the management of restless leg syndrome, a disorder characterized by an urge to move the legs, leading to discomfort and difficulty in sleep. L-DOPA may also have a beneficial effect in certain types of dystonia, a neurological movement disorder.

Product Packing:

试剂包装2

Additional Information:

Composition C9H11NO3
Assay 99%
Appearance White powder
CAS No. 556-03-6
Packing Small and bulk
Shelf Life 2 years
Storage Store in cool and dry area
Certification ISO.

 


  • Previous:
  • Next:

  • Write your message here and send it to us